STAGE IIB BREAST CANCER
Clinical trials for STAGE IIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breast cancer radiation cut to just 9 days in new trial
Disease control CompletedThis phase II trial tested a 9-day course of whole breast radiation (hypofractionated radiotherapy) in 102 patients with early-stage breast cancer (stages 0-IIB). The goal was to see if a shorter treatment schedule could maintain good cosmetic outcomes and quality of life while r…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
New drug cocktail shows promise against aggressive breast cancer
Disease control CompletedThis study tested a combination of two targeted antibodies (pertuzumab and trastuzumab) plus a chemotherapy drug (nab-paclitaxel) in 63 patients with HER2-positive advanced breast cancer. The goal was to see if this triple therapy could shrink tumors or delay the cancer from gett…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two drugs, fulvestrant and palbociclib, in older patients with hormone-sensitive breast cancer who either couldn't have surgery or chose not to. The goal was to see if the treatment could control the cancer for at least a year without needing su…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study looked at whether shutting down the ovaries (ovarian suppression) combined with hormone therapy (tamoxifen or exemestane) could better prevent breast cancer from coming back in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women who had surgery t…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC